Journal
ANNALS OF NEUROLOGY
Volume 73, Issue 2, Pages 303-308Publisher
WILEY-BLACKWELL
DOI: 10.1002/ana.23813
Keywords
-
Categories
Funding
- National Cancer Institute [U01-CA141549-01, R01-CA136573]
- National Eye Institute [EY02687]
- National Institutes of Health [RC4 NS072916]
- W.M. Keck Foundation
Ask authors/readers for more resources
Although traditional models of carcinogenesis have largely focused on neoplastic cells, converging data have revealed the importance of non-neoplastic stromal cells in influencing tumor growth and progression. Leveraging a genetically engineered mouse model of neurofibromatosis type 1 (NF1)-associated optic glioma, we now demonstrate that stromal microglia express the CX3CR1 chemokine receptor, such that reduced CX3CR1 expression decreases optic nerve microglia. Moreover, genetic reduction of Cx3cr1 expression in Nf1 optic glioma mice delays optic glioma formation. Coupled with previous findings demonstrating that microglia maintain optic glioma growth, these new findings provide a strong preclinical rationale for the development of future stroma-directed glioma therapies in children. ANN NEUROL 2013;73:303308
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available